) was a big mover last session, as the company saw its shares rise
by nearly 10% on the day. The move came on solid volume too with
far more shares changing hands than in a normal session. This
breaks the recent trend of the company, as the stock is now trading
above the volatile price range of $2.25 to $2.81 in the past
one-month time frame.
This biotechnology company has seen a mixed track record when it
comes to estimate revisions. Over the past one month, 5 estimates
moved north and the same number of estimates were revised lower.
The Zacks Consensus Estimate however remained unchanged during this
time frame. The recent price action is encouraging though, so make
sure to keep a close watch on this firm in the near future.
Dendreon currently has a Zacks Rank #3 (Hold) while its
Investors interested in the med-biomed industry may consider stocks
Gilead Sciences Inc.
). While Actelion holds a Zacks Rank #1 (Strong Buy), Amgen and
Gilead Sciences carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
AMGEN INC (AMGN): Free Stock Analysis Report
DENDREON CORP (DNDN): Free Stock Analysis
GILEAD SCIENCES (GILD): Free Stock Analysis
To read this article on Zacks.com click here.